These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10636303)

  • 1. The role of cognitive and affective processing in a transgenic mouse model of cortical-limbic neuropotentiated compulsive behavior.
    McGrath MJ; Campbell KM; Burton FH
    Behav Neurosci; 1999 Dec; 113(6):1249-56. PubMed ID: 10636303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral effects of cocaine on a transgenic mouse model of cortical-limbic compulsion.
    Campbell KM; McGrath MJ; Burton FH
    Brain Res; 1999 Jul; 833(2):216-24. PubMed ID: 10375697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiety in a transgenic mouse model of cortical-limbic neuro-potentiated compulsive behavior.
    McGrath MJ; Campbell KM; Veldman MB; Burton FH
    Behav Pharmacol; 1999 Sep; 10(5):435-43. PubMed ID: 10780249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OCD-Like behaviors caused by a neuropotentiating transgene targeted to cortical and limbic D1+ neurons.
    Campbell KM; de Lecea L; Severynse DM; Caron MG; McGrath MJ; Sparber SB; Sun LY; Burton FH
    J Neurosci; 1999 Jun; 19(12):5044-53. PubMed ID: 10366637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential response of cortical-limbic neuropotentiated compulsive mice to dopamine D1 and D2 receptor antagonists.
    Campbell KM; McGrath MJ; Burton FH
    Eur J Pharmacol; 1999 Apr; 371(2-3):103-11. PubMed ID: 10357247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TS+OCD-like neuropotentiated mice are supersensitive to seizure induction.
    Campbell KM; Veldman MB; McGrath MJ; Burton FH
    Neuroreport; 2000 Jul; 11(10):2335-8. PubMed ID: 10923696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder.
    McGrath MJ; Campbell KM; Parks CR; Burton FH
    Brain Res; 2000 Sep; 877(1):23-30. PubMed ID: 10980239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry.
    Nordstrom EJ; Burton FH
    Mol Psychiatry; 2002; 7(6):617-25, 524. PubMed ID: 12140785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical markers of striatal desensitization in cortical-limbic hyperglutamatergic TS- & OCD-like transgenic mice.
    O'Brien KB; Sharrief AZ; Nordstrom EJ; Travanty AJ; Huynh M; Romero MP; Bittner KC; Bowser MT; Burton FH
    J Chem Neuroanat; 2018 Apr; 89():11-20. PubMed ID: 29481900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of odor perception delineates functional disintegration of the limbic circuits in mesial temporal lobe epilepsy.
    Ciumas C; Lindström P; Aoun B; Savic I
    Neuroimage; 2008 Jan; 39(2):578-92. PubMed ID: 17951077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current and emerging features of obsessive-compulsive disorder--trends for the revision of DSM-5].
    Matsunaga H
    Seishin Shinkeigaku Zasshi; 2012; 114(9):1023-30. PubMed ID: 23198591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain circuitry of compulsivity.
    van den Heuvel OA; van Wingen G; Soriano-Mas C; Alonso P; Chamberlain SR; Nakamae T; Denys D; Goudriaan AE; Veltman DJ
    Eur Neuropsychopharmacol; 2016 May; 26(5):810-27. PubMed ID: 26711687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compulsivity in obsessive-compulsive disorder and addictions.
    Figee M; Pattij T; Willuhn I; Luigjes J; van den Brink W; Goudriaan A; Potenza MN; Robbins TW; Denys D
    Eur Neuropsychopharmacol; 2016 May; 26(5):856-68. PubMed ID: 26774279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Challenge to understand the neurobiology of obsessive-compulsive disorder].
    Tanaka K
    Brain Nerve; 2012 Aug; 64(8):903-9. PubMed ID: 22868881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emotional Processing in Obsessive-Compulsive Disorder: A Systematic Review and Meta-analysis of 25 Functional Neuroimaging Studies.
    Thorsen AL; Hagland P; Radua J; Mataix-Cols D; Kvale G; Hansen B; van den Heuvel OA
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Jun; 3(6):563-571. PubMed ID: 29550459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential frontal-striatal and paralimbic activity during reversal learning in major depressive disorder and obsessive-compulsive disorder.
    Remijnse PL; Nielen MM; van Balkom AJ; Hendriks GJ; Hoogendijk WJ; Uylings HB; Veltman DJ
    Psychol Med; 2009 Sep; 39(9):1503-18. PubMed ID: 19171077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S; Harvey BH
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EEG power modifications in obsessive-compulsive disorder during olfactory stimulation.
    Locatelli M; Bellodi L; Grassi B; Scarone S
    Biol Psychiatry; 1996 Mar; 39(5):326-31. PubMed ID: 8704063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compulsive habits in restless legs syndrome patients under dopaminergic treatment.
    Pourcher E; Rémillard S; Cohen H
    J Neurol Sci; 2010 Mar; 290(1-2):52-6. PubMed ID: 19969309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting response to cognitive behavioral therapy in contamination-based obsessive-compulsive disorder from functional magnetic resonance imaging.
    Olatunji BO; Ferreira-Garcia R; Caseras X; Fullana MA; Wooderson S; Speckens A; Lawrence N; Giampietro V; Brammer MJ; Phillips ML; Fontenelle LF; Mataix-Cols D
    Psychol Med; 2014 Jul; 44(10):2125-37. PubMed ID: 24229474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.